Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019

Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019 provides an overview of Topical Absorbable Hemostats currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Topical Absorbable Hemostats pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Topical Absorbable Hemostats under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Topical Absorbable Hemostats under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Topical Absorbable Hemostats Overview
  • Products under Development
    • Topical Absorbable Hemostats - Pipeline Products by Stage of Under Development
      • Table Figure 1: Topical Absorbable Hemostats - Pipeline Products by Stage of Under Development
      • Table Topical Absorbable Hemostats - Pipeline Products by Stage of Under Development
    • Topical Absorbable Hemostats - Pipeline Products by Segment
      • Table Figure 2: Topical Absorbable Hemostats - Pipeline Products by Segment
      • Table Topical Absorbable Hemostats - Pipeline Products by Segment
    • Topical Absorbable Hemostats - Pipeline Products by Territory
      • Table Figure 3: Topical Absorbable Hemostats - Pipeline Products by Territory
      • Table Topical Absorbable Hemostats - Pipeline Products by Territory
    • Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
      • Table Figure 4: Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
      • Table Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
    • Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
      • Table Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
    • Topical Absorbable Hemostats - Ongoing Clinical Trials
      • Table Figure 6: Topical Absorbable Hemostats - Ongoing Clinical Trials
      • Table Topical Absorbable Hemostats - Ongoing Clinical Trials
  • Topical Absorbable Hemostats - Pipeline Products under Development by Companies
    • Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
      • Table Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
    • Topical Absorbable Hemostats - Pipeline Products by Stage of Development
      • Table Topical Absorbable Hemostats - Pipeline Products by Stage of Development
  • Topical Absorbable Hemostats Companies and Product Overview
    • 3-D Matrix Ltd Company Overview
      • 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PuraStat Hemostat - Product Status
        • Table PuraStat Hemostat - Product Description
        • Table TDM-511 - Product Status
        • Table TDM-511 - Product Description
        • Table TDM-623 - Product Status
        • Table TDM-623 - Product Description
        • Table 3-D Matrix Ltd - Ongoing Clinical Trials Overview
        • Table PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection
        • Table PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery
        • Table PuraStat Hemostat - A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding
        • Table PuraStat Hemostat - The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
    • Angiotech Pharmaceuticals Inc Company Overview
      • Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemaseel Thrombin Haemostatic Agent - Product Status
        • Table Hemaseel Thrombin Haemostatic Agent - Product Description
    • Anika Therapeutics Inc Company Overview
      • Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Patch - Product Status
        • Table Hemostatic Patch - Product Description
    • APRUS Bio-Medical Innovations Pvt Ltd Company Overview
      • APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Deep Wound Hemostat - Product Status
        • Table Deep Wound Hemostat - Product Description
    • Arch Therapeutics Inc Company Overview
      • Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AC5 - V - Product Status
        • Table AC5 - V - Product Description
        • Table AC5 Surgical Hemostatic Device - Product Status
        • Table AC5 Surgical Hemostatic Device - Product Description
        • Table AC5 Topical Gel - Product Status
        • Table AC5 Topical Gel - Product Description
        • Table Arch Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table AC5 Topical Gel - AC5 Topical Gel Skin Sensitization Study
    • Baxter Healthcare Corp Company Overview
      • Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Celstat Topical Hemostatic Dressing - Product Status
        • Table Celstat Topical Hemostatic Dressing - Product Description
    • Baxter International Inc Company Overview
      • Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FloSeal Matrix Hemostatic Sealant - Product Status
        • Table FloSeal Matrix Hemostatic Sealant - Product Description
        • Table Hemopatch - Product Status
        • Table Hemopatch - Product Description
        • Table Hemopatch - Dural Defects - Product Status
        • Table Hemopatch - Dural Defects - Product Description
        • Table TISSEEL - Product Status
        • Table TISSEEL - Product Description
        • Table Baxter International Inc - Ongoing Clinical Trials Overview
        • Table FloSeal Matrix Hemostatic Sealant - Blood-saving Effect of Combined Intravenous Tranexamic Acid with Topical Floseal Application, a Comparison with Intravenous Tranexamic Acid Only in Total Hip Arthroplasty
        • Table FloSeal Matrix Hemostatic Sealant - Effectiveness of Gelatin Matrix with Human Derived Thrombin on Blood Loss, Surgical Time, Hospital Stay and Complications in Adolescents Undergoing Spine Surgery for Adolescent Idiopathic Scoliosis: A Randomized Clinical Trial
        • Table FloSeal Matrix Hemostatic Sealant - Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery
        • Table FloSeal Matrix Hemostatic Sealant - Impact of Electrocoagulation Versus a Gelantine-Thrombin Matrix Sealant (FloSeal) on Ovarian Reserve After Laparoscopic Stripping of Ovarian Endometriomas
        • Table FloSeal Matrix Hemostatic Sealant - Intraoperative Bleeding Control with Thrombin-Gelatin-Matrix (Floseal) in Advanced Gynecologic Surgery. A Case-control Study with Special Focus on Hemostasis in Patients with Primary or Secondary Coagulapathies
        • Table FloSeal Matrix Hemostatic Sealant - Management of Persistent Anterior Epistaxis Using Floseal Hemostatic Matrix vs. Traditional Nasal Packing: A Prospective Randomized Controlled Trial
        • Table FloSeal Matrix Hemostatic Sealant - Prospective, Randomised, Controlled Investigation Comparing the Safety and Performance of 032-11 Surgical Haemostat with FLOSEAL Haemostatic Matrix in Cardiac Surgery and Thoracic Aortic Surgery
        • Table FloSeal Matrix Hemostatic Sealant - The Role of Floseal in the Prevention of Lymphocele and Lymphatic Ascites After Lymph Node Dissection for Gynecologic Cancer: a Randomized Controlled Trial
        • Table TISSEEL - Modified Muller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue
        • Table TISSEEL - The Use of Fibrin Glue Sealant (Tisseel) as a Reinforcement of Esophagojejunal Anastomoses will Decrease the Rate of Anastomotic Leak
        • Table Hemopatch - A Phase II Prospective, Single Blinded, Randomized Trial of Hemopatch Compared to Standard Techniques to Achieve Air Leak Control After Complex Thoracic Surgical Procedures on High Risk Population for Prolonged Air Leak (more than 5 Days - PAL)
        • Table Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant
        • Table Hemopatch - A Single-arm Phase II Trial of Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy
        • Table Hemopatch - Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
        • Table Hemopatch - Exploratory Phase IV Randomized Single Blind Study Evaluating the Efficacy and Tolerability of Hemopatch in Improving Time of Hemostasis and Preventing Post-operative Complications After Hepatic Resection
        • Table Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the use of the New Hemostatic Patch Hemopatch in Patients undergoing Surgical Liver Resection
        • Table Hemopatch - Prospective Pilot Study for the Efficacy and Security Analysis in the Protection of Ileocolic Anastomosis Conducted in Laparoscopic Right Hemicolectomy Because of Colon Cancer, Using a Using a NHS-PEG (N-hydroxysuccinimide Functionalized Polyethylene Glycol) Coated Collagen Patch
        • Table Hemopatch - Prospective, Multicenter, Open-label, Randomized, Phase III Clinical Trial of Prevention of Prolonged Air Leak after Lung Resection in High-risk Patients, Applying HEMOPATCH
        • Table Hemopatch - Use of Hemopatch as a Sealant at the Pancreaticojejunostomy after Pancreatoduodenectomy to Prevent Postoperative Pancreatic Fistula
    • Beth Israel Deaconess Medical Center Inc Company Overview
      • Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portable Wound Hemostasis System - Product Status
        • Table Portable Wound Hemostasis System - Product Description
    • Biomedica Management Corp Company Overview
      • Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClotFoam - Product Status
        • Table ClotFoam - Product Description
        • Table ClotGel - Product Status
        • Table ClotGel - Product Description
        • Table ClotSpray - Product Status
        • Table ClotSpray - Product Description
    • Biom'Up SAS Company Overview
      • Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table HEMOSNOW - Product Status
        • Table HEMOSNOW - Product Description
    • C. R. Bard Inc Company Overview
      • C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table New Hemostat 1 - Product Status
        • Table New Hemostat 1 - Product Description
        • Table New Hemostat 2 - Product Status
        • Table New Hemostat 2 - Product Description
    • Cellphire Inc Company Overview
      • Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thromboderm - Product Status
        • Table Thromboderm - Product Description
        • Table Thrombosomes - Product Status
        • Table Thrombosomes - Product Description
        • Table Cellphire Inc - Ongoing Clinical Trials Overview
        • Table Thrombosomes - A Phase I, Multi-center, Open-label, Dose Escalation Study of Thrombosomes in Bleeding Thrombocytopenic Patients in Three Cohorts
    • Ceramicos Para Aplicacoes Medicas SA Company Overview
      • Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoKi - Product Status
        • Table HemoKi - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Wound Dressing - Product Status
        • Table Hemostatic Wound Dressing - Product Description
    • Covalent Medical, Inc. (Inactive) Company Overview
      • Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CovaSTAT - Product Status
        • Table CovaSTAT - Product Description
    • Covalon Technologies Ltd Company Overview
      • Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColActive THP - Product Status
        • Table ColActive THP - Product Description
        • Table CovaStat BioActive Absorbable Hemostatic Sponge - Product Status
        • Table CovaStat BioActive Absorbable Hemostatic Sponge - Product Description
    • Cresilon Inc Company Overview
      • Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TRAUMAGEL - Product Status
        • Table TRAUMAGEL - Product Description
        • Table VETIGEL - Product Status
        • Table VETIGEL - Product Description
    • CryoLife Inc Company Overview
      • CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PerClot - Product Status
        • Table PerClot - Product Description
    • Endomedix Incorporated Company Overview
      • Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
        • Table Surgical Hemostat - Intracranial Surgery - Product Status
        • Table Surgical Hemostat - Intracranial Surgery - Product Description
        • Table Topical Hemostat - Product Status
        • Table Topical Hemostat - Product Description
    • Entegrion Inc Company Overview
      • Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stasix - Product Status
        • Table Stasix - Product Description
    • Ethicon US LLC Company Overview
      • Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Gen Hemostat Kit - Product Status
        • Table Next Gen Hemostat Kit - Product Description
        • Table SURGIFLO - Sterile Field Preparation - Product Status
        • Table SURGIFLO - Sterile Field Preparation - Product Description
    • ETX Pharma Inc Company Overview
      • ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ETX-302 - Product Status
        • Table ETX-302 - Product Description
    • Gamma Therapeutics Inc Company Overview
      • Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GammaTF - Product Status
        • Table GammaTF - Product Description
    • GATT Technologies BV Company Overview
      • GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table GATT-Patch - Product Status
        • Table GATT-Patch - Product Description
        • Table GATT-Powder - Product Status
        • Table GATT-Powder - Product Description
    • gel-e Inc Company Overview
      • gel-e Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table gel-e Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemogrip Spray-On Foam - Product Status
        • Table Hemogrip Spray-On Foam - Product Description
        • Table LifeFoam - Product Status
        • Table LifeFoam - Product Description
    • Haemostatix Ltd Company Overview
      • Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HaemoPlax - Product Status
        • Table HaemoPlax - Product Description
        • Table PeproStat - Product Status
        • Table PeproStat - Product Description
    • Hemostasis LLC Company Overview
      • Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ENT Hemostat - Product Status
        • Table ENT Hemostat - Product Description
        • Table Hemostatic Gel - Product Status
        • Table Hemostatic Gel - Product Description
    • HLL Lifecare Ltd Company Overview
      • HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table External Haemostat - Product Status
        • Table External Haemostat - Product Description
    • Keratin Biosciences Inc Company Overview
      • Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratin-Based Hemostat - Product Status
        • Table Keratin-Based Hemostat - Product Description
    • Leader Biomedical Europe BV Company Overview
      • Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Collagen-Based Haemostatic Device - Product Status
        • Table Collagen-Based Haemostatic Device - Product Description
    • LifeBond Ltd Company Overview
      • LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Absorbable Hemostats - Product Status
        • Table Absorbable Hemostats - Product Description
    • Protege Biomedical Company Overview
      • Protege Biomedical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protege Biomedical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ionic Hemostatic Mineral Bandage - Emergency Trauma - Product Status
        • Table Ionic Hemostatic Mineral Bandage - Emergency Trauma - Product Description
    • Resorba GmbH Company Overview
      • Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibiotic Hemostat - Product Status
        • Table Antibiotic Hemostat - Product Description
        • Table RESORBA - Cardiac Surgery - Product Status
        • Table RESORBA - Cardiac Surgery - Product Description
    • Rice University Company Overview
      • Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table KOD Hydrogel Hemostat - Product Status
        • Table KOD Hydrogel Hemostat - Product Description
    • Sanara MedTech Inc Company Overview
      • Sanara MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sanara MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemaQuell - Product Status
        • Table HemaQuell - Product Description
    • Sanofi Biosurgery Inc Company Overview
      • Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table LeSeal - Product Status
        • Table LeSeal - Product Description
        • Table Lumagel - Product Status
        • Table Lumagel - Product Description
    • Sea Run Holdings Inc Company Overview
      • Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SEA-STAT - Product Status
        • Table SEA-STAT - Product Description
    • St Teresa Medical Inc Company Overview
      • St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SURGICLOT - Product Status
        • Table SURGICLOT - Product Description
        • Table WRAPCLOT - Product Status
        • Table WRAPCLOT - Product Description
    • Tectum Company Overview
      • Tectum Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tectum Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tectum Hemostatic Gel - Product Status
        • Table Tectum Hemostatic Gel - Product Description
        • Table Wound Dressing With Hemostat - Product Status
        • Table Wound Dressing With Hemostat - Product Description
    • The Medicines Company Company Overview
      • The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fibropad Patch - Product Status
        • Table Fibropad Patch - Product Description
    • Therus Corporation Company Overview
      • Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therus Acoustic Hemostasis System - Product Status
        • Table Therus Acoustic Hemostasis System - Product Description
    • Thrombotargets Corp Company Overview
      • Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation TT-173 - Product Status
        • Table Next Generation TT-173 - Product Description
        • Table TT-173 - Product Status
        • Table TT-173 - Product Description
        • Table Thrombotargets Corp - Ongoing Clinical Trials Overview
        • Table TT-173 - A Phase II/III, Randomized, Controlled, Single Blind Study to Evaluate the Haemostatic Efficacy and Safety of Topically Applied TT-173 in Patients Undergoing Knee Arthroplasty
    • United Health Products, Inc. Company Overview
      • United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoStyp External Procedure Gauze - Product Status
        • Table HemoStyp External Procedure Gauze - Product Description
        • Table HemoStyp Internal Procedure Gauze - Product Status
        • Table HemoStyp Internal Procedure Gauze - Product Description
        • Table Hemostyp Internal Procedure Gauze - Orthopedic - Product Status
        • Table Hemostyp Internal Procedure Gauze - Orthopedic - Product Description
        • Table HemoStyp Trauma Gauze - Product Status
        • Table HemoStyp Trauma Gauze - Product Description
    • University of Grenoble Alpes Company Overview
      • University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bleeding Controlling Device - Product Status
        • Table Bleeding Controlling Device - Product Description
    • Virginia Commonwealth University Company Overview
      • Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioHemostat - Product Status
        • Table BioHemostat - Product Description
    • Xcede Technologies Inc Company Overview
      • Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xcede - Femoral Artery - Product Status
        • Table Xcede - Femoral Artery - Product Description
        • Table Xcede - Laparoscopic Surgery - Product Status
        • Table Xcede - Laparoscopic Surgery - Product Description
        • Table Xcede - Lung Sealing - Product Status
        • Table Xcede - Lung Sealing - Product Description
        • Table Xcede - Vascular Surgery - Product Status
        • Table Xcede - Vascular Surgery - Product Description
        • Table Xcede Patch - Liver Resection - Product Status
        • Table Xcede Patch - Liver Resection - Product Description
  • Topical Absorbable Hemostats- Recent Developments
    • Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
    • Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships
    • Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn
    • Oct 31, 2019: gel-e announces breakthrough status designation from the U.S. Food and Drug Administration (FDA) for its first internal-use flowable device
    • Oct 31, 2019: Sanofi Q3 well on track
    • Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran
    • Oct 30, 2019: CryoLife reports third quarter 2019 financial results
    • Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019
    • Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results
    • Oct 24, 2019: Anika reports third quarter 2019 financial results
    • Oct 23, 2019: HemoStyp human trial results journal article to be submitted for peer review
    • Oct 23, 2019: Notification regarding application for the manufacture and sales approval of the absorbable local hemostat (TDM- 621)
    • Oct 21, 2019: Sean Salmon named executive vice president and group president of Medtronic Diabetes
    • Oct 18, 2019: United Health products announces positive results from HemoStyp Human Clinical Trial
    • Oct 17, 2019: United Health products to move manufacturing to U.S.
    • Oct 15, 2019: Sanofi opens digital manufacturing facility in the US
    • Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results
    • Oct 14, 2019: Anika appoints Mira Leiwant as vice president of regulatory affairs, quality, and clinical affairs
    • Oct 08, 2019: Samyang Biopharm USA expands and strengthens its US operations and makes additions to executive team in key business areas
    • Oct 08, 2019: United Health Products files defamation lawsuit against short sellers
    • Oct 07, 2019: Arch Therapeutics provides corporate update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
    • Oct 04, 2019: United Health Products announces submission of premarket approval Application to the U.S. FDA for the HemoStyp device for use in surgical procedures
    • Sep 30, 2019: Notice regarding product registration obtained in Argentina (Absorbable Hemostat "TDM-621")
    • Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe
    • Sep 30, 2019: Biom'up announces approval of 2019 H1 interim results postponed: Board of Directors pursues review of options available to the Company
    • Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
    • Sep 11, 2019: Advanced Medical Solutions Group: Interim results for the six months ended 30 June 2019
    • Sep 06, 2019: United Health Products appoints Dr. Gerard Abate Chief Medical Director
    • Aug 28, 2019: United Health products announces completion of human trial study
    • Aug 28, 2019: Covalon announces third quarter fiscal 2019 results
    • Aug 28, 2019: Medtronic announces planned leadership succession
    • Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical
    • Aug 20, 2019: Medtronic reports first quarter financial results for 2019
    • Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors
    • Aug 14, 2019: New publication highlights application of HEMOBLAST Bellows in Cardiovascular Surgery
    • Aug 14, 2019: United Health products announces completion of pathology and study of preclinical bone application of HemoStyp
    • Aug 12, 2019: Stryker announces commercial structure realignment
    • Aug 07, 2019: Biom'up issues a new tranche of €5 million from the credit line granted by Athyrium
    • Aug 06, 2019: Endomedix to present its innovative technology addressing the needs of warfighters at the upcoming Military Health System and Research Symposium 2019 annual meeting
    • Aug 05, 2019: United Health products announces the completion of human trial surgery enrollment
    • Aug 05, 2019: Arch Therapeutics announces AC5 self-assembling peptide technology platform demonstrates antimicrobial activity in two studies and provides CE marking status update for AC5 topical hemostat
    • Jul 30, 2019: CryoLife reports second quarter 2019 financial results
    • Jul 29, 2019: Sanofi delivered solid growth in Q2 2019
    • Jul 29, 2019: Sanofi: Appointment of additional director and whole time director
    • Jul 26, 2019: Sanofi : Information on the departure conditions of Olivier Brandicourt, Chief Executive Officer
    • Jul 25, 2019: Covalon CEO provides corporate update
    • Jul 25, 2019: Baxter reports second-quarter 2019 results
    • Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019
    • Jul 25, 2019: Stryker reports second quarter 2019 operating results
    • Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
    • Jul 24, 2019: Anika reports second quarter 2019 financial results
    • Jul 22, 2019: Notification of completion of the recruitment for the clinical trials of absorbable hemostat (TDM-621)
    • Jul 19, 2019: Progress of UK POPS(Prospective Observational PuraStat Study)
    • Jul 18, 2019: Cellphire completes enrollment of phase 1 clinical trial of Thrombosomes
    • Jul 17, 2019: PuraStat Clinical User Group Symposium at BSG
    • Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results
    • Jul 10, 2019: Biom'up provides business update for the first half of 2019 and confirms its revenue guidance for the year
    • Jul 10, 2019: Biom'up provides business update for the first half of 2019 and confirms its revenue guidance for the year
    • Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning
    • Jun 27, 2019: Baxter highlights progress toward its 2020 corporate responsibility goals and efforts to make a meaningful difference around the world
    • Jun 19, 2019: Grifols to launch plasma-protein-based bleeding-control solutions
    • Jun 19, 2019: Ethicon announces 510(k) clearances for VISTASEAL open and laparoscopic dual applicator devices designed to deliver biologics that address surgical bleeding
    • Jun 18, 2019: Breakthrough device designation received from the FDA
    • Jun 14, 2019: Stryker to invest €200m in RD&I projects in Ireland
    • Jun 14, 2019: Drug Makers Sue to Block requirement for Listing Prices in TV Ads
    • Jun 13, 2019: 3-D Matrix appoints FUJIFILM Europe as their Europe-wide, exclusive distributor of PuraStat in Gastrointestinal endoscopic surgery indications
    • Jun 07, 2019: Paul Hudson to succeed Olivier Brandicourt as chief executive officer
    • Jun 05, 2019: Molecular bait can help hydrogels heal wounds
    • May 31, 2019: Industry veteran Dr. Jan Ohrstrom takes on executive leadership of Biom'up
    • May 28, 2019: Covalon announces second quarter fiscal 2019 results
    • May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results
    • May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research
    • May 20, 2019: Biom'up provides 2019 guidance for HEMOBLAST Bellows global sales
    • May 20, 2019: New study investigates safety and efficacy of Cook Medical's Hemospray in treating nonvariceal lower GI bleeds
    • May 15, 2019: Johnson & Johnson outlines strategy to deliver above-market growth at 2019 pharmaceutical business review
    • May 09, 2019: WNDM Medical - reverse stock split and company name change to Sanara Medtech to be effective on may 10, 2019
    • May 03, 2019: Cadila Pharmaceuticals provides up-date on USFDA inspected at its formulations manufacturing facility in Ahmedabad, India
    • May 02, 2019: Anika reports first quarter 2019 financial results
    • Apr 30, 2019: Anika Therapeutics names Stephen Goldy as vice president of U.S. Sales
    • Apr 30, 2019: CryoLife Reports First Quarter 2019 Financial Results
    • Apr 30, 2019: Biom'up reports 2018 full-year results and confirms strong commercial uptake in 1st quarter of 2019
    • Apr 30, 2019: Biom'up reports 2018 full-year results and provides a business update
    • Apr 26, 2019: Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
    • Apr 25, 2019: Baxter reports first-quarter 2019 results
    • Apr 25, 2019: The Medicines Company reports first-quarter 2019 financial results and significant progress with the Inclisiran clinical development program
    • Apr 24, 2019: Biom'up granted FDA IDE approval for HEMOSNOW
    • Apr 24, 2019: Arch Therapeutics announces Attendance at 2019 Symposium on Advanced Wound Care Conference (SAWC) and release of a new AC5 Topical Gel Video
    • Apr 23, 2019: Stryker announces first quarter 2019 operating results
    • Apr 23, 2019: Merit Medical announces earnings for quarter ended March 31, 2019
    • Apr 16, 2019: Johnson & Johnson reports 2019 first-quarter results
    • Apr 09, 2019: Baxter unveils the latest evolution of Floseal at AORN Meeting
    • Apr 09, 2019: Merit Medical announces opening of new office in Johannesburg, South Africa
    • Apr 02, 2019: United Health Products announces 2018 results
    • Mar 29, 2019: PolarityTE announces Richard Hague, formerly from Sanofi, Genzyme and recently Anika Therapeutics as Chief Operating Officer
    • Mar 27, 2019: Stryker announces new Vice President, chief legal officer
    • Mar 25, 2019: WNDM Medical announces planned reverse stock split and company name change to Sanara Medtech
    • Mar 25, 2019: Medtronic launches Medtech Innovation Accelerator in Shanghai
    • Mar 18, 2019: Anika Therapeutics names Robert Richard as Vice President of research and development
    • Mar 18, 2019: Mr. Ron Smith Joins Covalon's Board of Directors and is appointed Chair of the Audit Committee
    • Mar 14, 2019: Medtronic names Andrea J. Goldsmith as a new director
    • Mar 13, 2019: Advanced Medical Solutions Group : Unaudited preliminary results for the year ended 31 December 2018
    • Mar 01, 2019: Pius S. Hornstein, PhD, appointed new country chair of Sanofi China
    • Feb 27, 2019: The Medicines Company announces fourth-quarter and full year 2018 business and financial results
    • Feb 26, 2019: Covalon announces first quarter fiscal 2019 results and updates plans for fiscal 2019
    • Feb 21, 2019: Anika reports fourth quarter and full year 2018 financial results
    • Feb 19, 2019: Medtronic reports third quarter financial results
    • Feb 13, 2019: CryoLife Reports Fourth Quarter and Full Year 2018 Financial Results
    • Feb 12, 2019: Sanofi names Ameet Nathwani as chief digital officer
    • Feb 08, 2019: Johnson & Johnson to disclose drug prices in television ads
    • Feb 07, 2019: Sanofi delivers 2018 business EPS growth of 5.1% at CER
    • Feb 06, 2019: Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director
    • Feb 01, 2019: WNDM Medical announces chairmanship change on February 1, 2019
    • Jan 31, 2019: Biom'up appoints George Makhoul as chief commercial officer (USA)
    • Jan 31, 2019: Baxter reports 2018 fourth-quarter and full-year results
    • Jan 30, 2019: Biom'up HEMOBLAST Bellows full pivotal trial results published in Journal of Cardiac Surgery
    • Jan 30, 2019: Mr. John Suk Joins Covalon's Board of Directors
    • Jan 29, 2019: Stryker reports 2018 results and 2019 outlook
    • Jan 28, 2019: Covalon Technologies names Dr. Myrna Francis as board director
    • Jan 24, 2019: Official launch of Hemoblast bellows in Spain
    • Jan 23, 2019: Absorbable Hemostat "TDM-621" product registration obtained in Canada
    • Jan 23, 2019: Sanofi joins Startup Creasphere - Munich's first digital health focused innovation program
    • Jan 22, 2019: Johnson & Johnson reports 2018 fourth-quarter results
    • Jan 21, 2019: gel-e expands patent estate
    • Jan 15, 2019: Partnership agreement concluded with vantage endoscopy regarding sales and marketing of absorbable local hemostat "PuraStat" in Canada
    • Jan 11, 2019: Pre-quarterly results communication
    • Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
    • Jan 07, 2019: Biom'up submits IDE application to the FDA for HEMOSNOW
    • Jan 07, 2019: Biom'up announces renewal of its supply agreement for thrombin, a key component of HEMOBLAST Bellows
    • Jan 03, 2019: Merit Medical names Jill Anderson and Elizabeth Huebner as Board Directors
    • Dec 31, 2018: Advanced Medical Solutions Group announces board change
    • Dec 18, 2018: Baxter launches curved applicator for Floseal, expanding use of leading Hemostat during ENT procedures
    • Dec 18, 2018: Sanofi to transfer U.S. stock exchange listing to Nasdaq
    • Dec 18, 2018: Sanofi moving 2,700 staffers from the Boston suburbs to Cambridge crossing
    • Dec 17, 2018: Arch Therapeutics receives 510(k) clearance from the US FDA for AC5 Topical Gel
    • Dec 17, 2018: Covalon announces fiscal 2018 year-end results and plans for fiscal 2019
    • Dec 12, 2018: Endomedix announces submission of Patent Application for Advanced Hemostat Technology
    • Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine
    • Dec 06, 2018: Baxter International names Patricia Morrison and Amy Wendell to its Board
    • Dec 06, 2018: Arch Therapeutics provided corporate update at the 11th Annual LD Micro Main Event
    • Dec 05, 2018: Sanofi plans 670 job cuts in France by end 2020
    • Dec 04, 2018: Arch Therapeutics announces positive outcome of ruling from Japanese Intellectual Property High Court
    • Dec 04, 2018: Z-Medica names Chris Van Gorder, FACHE, to board of directors
    • Dec 03, 2018: LifeMax Laboratories names Kirk Johnson Ph.D. as VP of Preclinical Development
    • Dec 01, 2018: KYERON announces development of POWERCOL
    • Nov 28, 2018: Arch Therapeutics announces submission of CE Mark File for AC5 Topical Hemostat in Europe
    • Nov 28, 2018: Biom'up Sees a strong commercial uptake in HEMOBLAST Bellows in the US and Europe
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook